Pluri PLUR
NASDAQ PLUR
$1.01 -0.02 (-1.94%)
At close: Oct 2, 2026 · 4:00 PM EDT

Pluri (PLUR) Return on Capital Employed [ROCE] (2011 - 2025)

Updated

Pluri's Return on Capital Employed [ROCE] came in at -580.66% for fiscal Q1 2026 (quarter ended Sep 30, 2025), down 513.86 percentage points from -66.80% a year earlier and down 192.76 percentage points from the prior quarter.

Analysis

Pluri (PLUR) Return on Capital Employed [ROCE] (2011 - 2025) Analysis & Trends

For FY2025 (ended Jun 30, 2025), Pluri's Return on Capital Employed [ROCE] was -327.22%, down 272.79 percentage points from FY2024.

  • Return on Capital Employed [ROCE] carries a five-year change of -254.33 percentage points (FY2020 to FY2025).
  • Going back by fiscal year, Return on Capital Employed [ROCE] was -54.43% in FY2024 (-3.80 pp), -50.63% in FY2023 (+5.59 pp), -56.23% in FY2022 (+18.20 pp) and -74.43% in FY2021 (-1.53 pp).
  • The fiscal Q1 2026 figure represents the lowest quarterly Return on Capital Employed [ROCE] in data going back to fiscal Q1 2012.
  • Year-over-year, Return on Capital Employed [ROCE] has declined for eight consecutive quarters, with an average year-over-year change of -110.93 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in fiscal Q3 2021 (a gain of 92.76 percentage points), and the weakest in fiscal Q1 2026 (a drop of 513.86 percentage points).
  • Business Quant data shows PLUR's Return on Capital Employed [ROCE] at -387.90% (Q4 2025), -75.94% (Q3 2025) and -75.66% (Q2 2025) in the three fiscal quarters before Q1 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Pluri 10.93 Mn -1.84 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -580.66%
Jun 30, 2025 -387.90%
Mar 31, 2025 -75.94%
Dec 31, 2024 -75.66%
Sep 30, 2024 -66.80%
Jun 30, 2024 -66.13%
Mar 31, 2024 -65.80%
Dec 31, 2023 -62.91%
Sep 30, 2023 -59.29%
Jun 30, 2023 -56.88%
Mar 31, 2023 -56.13%
Dec 31, 2022 -60.41%
Sep 30, 2022 -62.95%
Jun 30, 2022 -62.30%
Mar 31, 2022 -65.39%
Dec 31, 2021 -70.05%
Sep 30, 2021 -68.13%
Jun 30, 2021 -67.64%
Mar 31, 2021 -79.84%
Dec 31, 2020 -82.71%
API Access

Pluri Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=PLUR&period=max&api_key=YOUR_API_KEY